APLI:CA Appili Therapeutics Inc

CAD 0.04 0.00 0
Icon

Appili Therapeutics Inc (APLI:CA) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | TSX
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

CAD 0.04

0.00 (0.00)%

CAD 4.24M

0.01M

N/A

N/A

Icon

APLI:CA

Appili Therapeutics Inc (CAD)
COMMON STOCK | TSX
CAD 0.04
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

CAD 4.24M

N/A

CAD 0.04

Appili Therapeutics Inc (APLI:CA) Stock Forecast

N/A

Based on the Appili Therapeutics Inc stock forecast from 0 analysts, the average analyst target price for Appili Therapeutics Inc is not available over the next 12 months. Appili Therapeutics Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Appili Therapeutics Inc is Slightly Bearish, which is based on 3 positive signals and 6 negative signals. At the last closing, Appili Therapeutics Inc’s stock price was CAD 0.035. Appili Therapeutics Inc’s stock price has changed by +16.67% over the past week, -12.50% over the past month and -41.67% over the last year.

No recent analyst target price found for Appili Therapeutics Inc
No recent average analyst rating found for Appili Therapeutics Inc

Company Overview Appili Therapeutics Inc

Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in infectious disease in Canada. Its anti-infective portfolio includes ATI-1501, a taste-masked liquid oral suspension formulation of the antibioti...Read More

#21-1344 Summer Street, Halifax, NS, Canada, B3H 0A8

0

December

CAD

Canada

Adjusted Closing Price for Appili Therapeutics Inc (APLI:CA)

Loading...

Unadjusted Closing Price for Appili Therapeutics Inc (APLI:CA)

Loading...

Share Trading Volume for Appili Therapeutics Inc Shares

Loading...

Compare Performance of Appili Therapeutics Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for APLI:CA

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Appili Therapeutics Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
FRX:CA
Fennec Pharmaceuticals Inc +0.18 (+2.04%) CAD0.24B 176.80 -33.83

ETFs Containing APLI:CA

Symbol Name APLI:CA's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Appili Therapeutics Inc (APLI:CA) Stock

Stock Target Advisor's fundamental analysis for Appili Therapeutics Inc's stock is Slightly Bearish.

Unfortunately we do not have enough data on APLI:CA's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on APLI:CA's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on APLI:CA's stock to indicate if its overvalued.

The last closing price of APLI:CA's stock was CAD 0.04.

The most recent market capitalization for APLI:CA is CAD 4.24M.

Unfortunately we do not have enough analyst data on APLI:CA's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Appili Therapeutics Inc's stock.

As per our most recent records Appili Therapeutics Inc has 0 Employees.

Appili Therapeutics Inc's registered address is #21-1344 Summer Street, Halifax, NS, Canada, B3H 0A8. You can get more information about it from Appili Therapeutics Inc's website at https://www.appilitherapeutics.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...